Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
1.225
-0.035 (-2.78%)
At close: Jul 19, 2024, 4:00 PM
1.240
+0.015 (1.22%)
Pre-market: Jul 22, 2024, 8:57 AM EDT
Seres Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$5.75
Upside
+369.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +716.33% | Jun 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +226.53% | May 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +389.80% | May 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +308.16% | Mar 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +553.06% | Mar 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +634.69% | Jan 16, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $1.25 | Strong Sell | Maintains | $4 → $1.25 | +2.04% | Nov 3, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $12 | Buy | Initiates | $12 | +879.59% | Jun 26, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +716.33% | Apr 28, 2023 |
| JP Morgan | JP Morgan | Hold Initiates $7 | Hold | Initiates | $7 | +471.43% | Apr 21, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $15 | Strong Buy | Maintains | $11 → $15 | +1,124.49% | Mar 21, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +797.96% | Mar 8, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +879.59% | Mar 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,940.82% | Mar 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,940.82% | Feb 8, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +634.69% | Sep 7, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $32 → $7 | Buy | Maintains | $32 → $7 | +471.43% | May 23, 2022 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 23, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 23, 2021 |
| Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 23, 2021 |